Suppr超能文献

人体口服地高辛后血清中洋地黄毒苷的定量分析。

Quantitation of digoxigenin in serum following oral administration of digoxin in humans.

作者信息

Loo J C, McGilveray I J, Jordan N

出版信息

Res Commun Chem Pathol Pharmacol. 1977 Jul;17(3):497-506.

PMID:897341
Abstract

Separation of the acid breakdown products from digoxin in serum was accomplished by high performance liquid chromatography (HPLC). The major, less cardioactive, product digoxigenin was quantitated by several different commercial antisera from digoxin radioimmunoassay (RIA) kits. When two normal subjects were given digoxigenin (0.5 mg) orally appreciable concentrations were detected by digoxin RIA kit. Administration of a digoxin (0.5 mg) solution to the same overnight-fasted recumbent volunteers resulted in digoxigenin detection (HPLC-RIA) in serum only in one subject.

摘要

采用高效液相色谱法(HPLC)从血清中的地高辛中分离出酸分解产物。主要的、心脏活性较低的产物洋地黄毒苷元通过地高辛放射免疫分析(RIA)试剂盒中的几种不同商业抗血清进行定量。当两名正常受试者口服洋地黄毒苷元(0.5毫克)时,地高辛RIA试剂盒检测到了相当可观的浓度。对同样隔夜禁食的卧位志愿者给予地高辛(0.5毫克)溶液后,仅在一名受试者的血清中检测到了洋地黄毒苷元(HPLC-RIA)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验